MYMARK
LIVE

Serial Number

88518725

Owner

NRJY, Inc.

Attorney

Matthew H Platt

First Use Date

Jul 15, 2019

Filing Date

Jul 17, 2019

Add to watchlist:

No watchlists yet
View on USPTO

MYMARK Trademark

Serial Number: 88518725 • Registration: 6049584

MYMARK is a trademark filed by NRJY, Inc. on July 17, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

NRJY, Inc. (2 trademarks)

2 rue d'Auteuil
Paris 75016 , FR

Entity Type: 03

Trademark Details

Filing Date

July 17, 2019

Registration Date

May 5, 2020

First Use Anywhere

July 15, 2019

First Use in Commerce

October 23, 2019

Published for Opposition

December 3, 2019

Goods & Services

Direct-to-consumer test kits containing laboratory research instruments, namely, pipette tips and inoculation loops, for taking samples for review for various medical conditions for research purposes

Medical diagnostic kits for taking and storing at-home culture sampling that are used for the ordering of direct-to-consumer laboratory tests for various medical conditions containing medical diagnostic reagents and also plastic storage receptacles; medical test kits primarily composed of medical diagnostic reagents and also alcohol pads for sterilizing fingers, finger-pricks for medical purposes, medical antigens, cotton sticks for medical purposes, medical adhesive tape, bandages for dressings, plastic storage receptacles specially adapted for the safe-transport of culture samples, and printed materials in the nature of instructions and mailing envelopes for testing the presence of medical conditions; medical test kits, featuring medical diagnostic reagents for monitoring various medical conditions and levels of substances, namely, cholesterol, thyroid, vitamins, hormones, kidney and liver functions; medical test kits featuring medical diagnostic reagents for monitoring various relevant medical markers, namely, STDs, cancer, genetic disorders, fertility-related hormone levels, and other laboratory testable blood markers; medical cancer screening kits featuring medical diagnostic reagents for detecting levels of prostate-specific antigens and the Papillomavirus

Medical services; reporting of information regarding results of testing for various medical conditions directly to the patient; health care services, namely, ordering and review of medical lab testing; medical diagnostic testing, monitoring, and reporting services; medical diagnostic testing for genetic anomalies and disorders, namely, collecting biological samples for laboratory testing for medical purposes, providing laboratory testing and diagnostic services thereto for medical purposes; medical information services, namely, reporting clinical test results to customers via secured mobile platform

Direct-to-consumer test kits containing medical instruments for taking samples for review for various medical conditions; medical diagnostic testing kits containing sterile medical specimen collection tools in the nature of lancets, swabs, saliva collection tubes, and collection cards for the collection of blood, urine, saliva, and feces for use in testing and for monitoring various medical conditions, and also including instructions and return shipping packaging

Medical and scientific research for providing information regarding results of testing for various medical conditions; providing scientific analysis and information regarding the results of laboratory testing in the field of various medical conditions; providing medical research information regarding results of testing for various medical conditions

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 5, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
May 5, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 31, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 30, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 17, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 13, 2020 AITU
USE AMENDMENT FILED
Feb 24, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 24, 2020 EISU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 24, 2020 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 24, 2020 CHAN
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 24, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 24, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 24, 2020 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 28, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 3, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 3, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 13, 2019 NONP
ASSIGNED TO LIE
Oct 30, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 23, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 23, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 23, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 23, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 23, 2019 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 10, 2019 GNRN
NON-FINAL ACTION E-MAILED
Oct 10, 2019 GNRT
NON-FINAL ACTION WRITTEN
Oct 10, 2019 CNRT
ASSIGNED TO EXAMINER
Oct 3, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 23, 2019 NWOS
NEW APPLICATION ENTERED
Jul 20, 2019 NWAP